Zimbabwe has turned down a major American health deal worth 367 million US dollars (272 million pounds) spanning five years over Washington's request for sensitive biological samples.
The decision became public after a official document dated December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government representative later explained that the US was requesting health data for research and profit while refused to guarantee the benefits from future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for more talks to find a agreement suitable to both sides so the nation's critical HIV programme can be sustained.
Broader Implications
This rejection follows a comparable case in neighbouring Kenya, where a high court halted a related deal with the US following legal challenges were filed about the security of citizens' health data.
Since returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government agreements to boost openness and accountability.
According to statements, 16 African countries have so far signed similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation could have provided immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment via American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," he stated.
"Put simply, our nation would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our population should a future disease outbreak emerge."
National Interest and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting systems already set up through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to manage potential pandemics.
"This mechanism is intended to guarantee that when a country provides its data, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," he added.
"We welcome further discussions with our US partners on how future co-operation might be arranged in a manner that honours the independence and interests of both nations."
Medical Community Response
A leading public health body stated it acknowledged the government's concerns, but recommended that talks should continue since much of the nation's Aids initiatives depended on international support.
"In cases where specific concerns exist, including those relating to data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," it commented.
This impasse highlights the ongoing tensions between accepting vital international aid and safeguarding local interests in an increasingly interconnected world.